STRATEGY

We will achieve our vision by continuing to profitably expand our current in vitro diagnostic and medical device businesses and will sustain long-term growth by exploiting the Company’s platform technologies:

OraSure^® . . . . . . Expand the use of OraSure^® for a broad range of laboratory-based oral fluid applications, especially infectious disease, substance abuse, and insurance risk assessment.

OraQuick^® . . . . . Establish OraQuick^® as the most versatile point-of-care device for infectious disease testing for the global public health marketplace.